Company intelligence / Profile preview

Nourilax

Irvine, California, United States

Ownership: Private
Development stage: Other

Overview

Nouri is a consumer health and biotechnology company focused on the gut-brain axis and microbiome health. The company develops and markets advanced probiotic and nutraceutical solutions that utilize a specialized capsule-in-capsule delivery system to ensure the viability of live biotherapeutics. Their product line targets specific health outcomes including digestive wellness, cognitive function, and immune support. By combining clinical-grade probiotic strains with plant-based oils, Nouri aims to provide more effective and bioavailable supplements for daily health management.

Therapeutic areas: ImmunologyPsychiatryNeurologyGastroenterology
Modalities: Live biotherapeutic product therapyProbioticsSmall molecule
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Nourilax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nourilax.

Explore the full profile